Page 94 of 94 FirstFirst ... 448485868788899091929394
Results 931 to 934 of 934

Thread: Spinal Cord Injury Articles Posted by Manouli

  1. #931
    Engineering a Solution to Spinal Cord Injuries
    The Engineer posted on November 23, 2017 | Comment

    Like an earthquake that ruptures a road, traumatic spinal cord injuries render the body's neural highway impassable. To date, there are neither workable repairs nor detours that will restore signal flow between the brain and limbs, reversing paralysis.
    "The problem with spinal cord injuries is that nerve cells do not regenerate," explained Treena Arinzeh, director of the New Jersey Institute of Technology's Tissue Engineering and Applied Biomaterials Lab, who has proposed a solution: a scaffold, made of an energetic polymer, that will coax nerve cells to extend their axons over the spine's damaged section.

  2. #932
    New trial aiming to repair injured spinal cords gives new hope to paralysed Australians

    ⦁ Anne-Marie Howarth was riding her motorcycle in the Blue Mountains when she went too fast on a bend, crashed into a barrier and "squashed" her spine, leaving her paralysed from the lower chest down.
    In the 12 years since, Ms Howarth, 43, never thought she would see a medical breakthrough that reversed spinal cord injuries in her lifetime, let alone in five years.
    But that's now the reality. A trial will begin in Sydney next year where scientists will use electrical currents to jump-start the broken spinal cords of quadriplegics.

  3. #933
    Junior Member
    Join Date
    Dec 2017
    Gothenburg, Sweden
    The thread was great... 94 pages packed with information, thank you!

  4. #934
    New Spinal Cord Injury Repair Company Launched
    Elizabeth Hofheinz, M.P.H., M.Ed. • Fri, August 18th, 2017
    Print this article
    Based on an innovative technology from Yale University which has shown promise to grow nerve fibers naturally and restore all facets of nerve function, a new company, ReNetX Bio (formerly known as Axerion Therapeutics), has been launched.
    ReNetX Bio is focused on providing physicians with a novel treatment for central nervous system injuries. Its inaugural CEO is Erika Smith, a 25-year veteran investor and entrepreneur who has invested in, managed and successfully exited numerous seed and early-stage investments with funding from Yale and Johnson & Johnson. Most recently, Ms. Smith was director of the Blavatnik Fund for Innovation at Yale University.
    The company also announced that it was seeking funding via a Series A financing to pay for its first clinical trial of its lead therapeutic candidate, Nogo Trap, in patients with chronic spinal cord injury.
    The company wrote in its July 24, 2017 news release, “ReNetX licensed the rights of the innovative neuro-restorative Nogo Receptor platform technology discovered by Stephen Strittmatter, M.D., Ph.D., at Yale University and founder and scientific advisor to ReNetX. The central nervous system contains major extracellular factors that limit regrowth of neurons. The company has developed a decoy receptor, called Nogo Trap, that binds the growth inhibitors allowing the body to grow nerve fibers naturally and directly targeting restoration across all facets of growth: axonal regeneration (long distance), axonal sprouting (medium distance) and synaptic plasticity.”

Similar Threads

  1. Replies: 0
    Last Post: 08-14-2005, 09:16 AM
  2. New articles posted to Research Forums.
    By Wise Young in forum Cure
    Replies: 1
    Last Post: 04-15-2004, 11:41 AM
  3. Replies: 0
    Last Post: 01-14-2004, 12:00 PM
  4. Replies: 8
    Last Post: 05-15-2003, 02:05 AM
  5. Replies: 1
    Last Post: 05-12-2002, 04:07 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts